NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the “Foundation”) today announced that it has awarded $5.25M to seven groundbreaking scientists at five premier institutions. For over a decade, the Foundation has advanced health initiatives in New York City by funding pioneering cancer researchers through the Pershing Square Sohn Cancer Research Alliance (“PSSCRA”). Expanding on its enduring commitment to cancer research and its broader investments in women’s health over the years,...
Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology, both from Weill Cornell Medicine, have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant.
NEW YORK, May 20, 2025 /PRNewswire/ -- The Lupus Research Alliance (LRA) today announced the launch of the Lupus Nexus Foundational Analyses, a major scientific initiative aimed at creating one of the most comprehensive and accessible lupus research datasets ever assembled. This effort will generate numerous molecular datasets using biospecimens collected through the Lupus Landmark Study, a key component of the Lupus Nexus. These molecular datasets, integrated with robust clinical data,...
Newswise — Infants hospitalized with severe COVID-19 have significantly different immune responses than adults or older children. The finding comes from scientists at St. Jude Children’s Research Hospital, The Jackson Laboratory for Genomic Medicine, Weill Cornell Medicine, Nationwide Children’s Hospital, Icahn School of Medicine at Mt. Sinai and Yale University. The researchers established the unique features of hospitalized infants’ immune cells during mild, moderate and severe COVID-19. The...
We are proud to announce that Dr. David C. Lyden, a member of the Gale and Ira Drukier Institute for Children's Health and the Sandra and Edward Meyer Cancer Center, has received the prestigious Special Achievement Award from the International Society for Extracellular Vesicles (ISEV). This distinguished honor, voted on by over 2,000 ISEV members, recognizes Dr. Lyden’s groundbreaking contributions to the field of extracellular vesicle (EV) research.
Provost Kavita Bala and professors Anurag Agrawal and Dr. M. Virginia Pascual have been elected to the American Academy of Arts and Sciences, the academy announced on April 23.
Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and University of California San Diego Health. Clots are the second-leading cause of death among cancer patients with advanced disease or aggressive tumors.
Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Korea’s Yonsei University. The discovery improves the scientific understanding of cancer progression and anticancer immunity, and could yield new clinical tools for assessing and reducing metastasis risk.
The highlight of this annual celebration is the presenting of the research grants to the three cancer institutions supported in the tristate area. Over the past thirty-six years, the Foundation has awarded 115 cancer research grants to various institutions in the New Jersey, New York, Pennsylvania and Delaware in the amount of $1,320,000.
Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according to a new study by Weill Cornell Medicine investigators.
